Race Oncology Company Profile, Contacts & Intelligence
Race Oncology Overview
Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care. Race’s lead asset, bisantrene, is a small molecule chemotherapeutic. Bisantrene has a rich and unique clinical history with demonstrated therapeutic benefits in both adult and paediatric patients, a well characterised safety profile, and compelling clinical data demonstrating an anticancer effect and less cardiotoxicity over certain anthracyclines, such as doxorubicin. Race is advancing a reformulated bisantrene (RC220) to address the high unmet needs of patients across multiple oncology indications, with a clinical focus on anthracycline combinations, where we hope to deliver cardioprotection and enhanced anti-cancer activity in solid tumours. Race is also exploring RC220 as a low intensity treatment for acute myeloid leukaemia. Race is investigating the effect of bisantrene on the m6A RNA pathway, following independent research published by the City of Hope identifying bisantrene as a potent inhibitor of FTO (Fat mass and obesity-associated protein). Dysregulation of the m6A RNA pathway has been described in numerous peer reviewed studies to be a driver of a diverse range of cancers. Race Oncology has collaborated with Astex, City of Hope, MD Anderson, Sheba City of Health, UNC School of Medicine, University of Wollongong and University of Newcastle, and is actively exploring partnerships, licence agreements or a commercial merger and acquisition to accelerate access to bisantrene for patients with cancer across the world. Learn more at www.raceoncology.com.
- Headquarters
- Au
- Website
- raceoncology.com
- Industry
- Pharmaceutical Manufacturing
- Founded
- 2016
- NAICS
- Pharmaceutical and Medicine Manufacturing, Medicinal and Botanical Manufacturing
- Phone Number
- Available in AeroLeads
- Company Email
- Available in AeroLeads
Race Oncology Contact Intelligence
See which contact channels and departments are represented in the visible AeroLeads data.
Race Oncology People & Org Chart Preview
Sample people records show job titles and whether email or phone data is available without exposing raw contact details.
Race Oncology Workforce Composition
Seniority breakdown across 8 visible profiles.
Race Oncology Technology & Talent
Technology-related job titles represented in the visible people data.
Compare Similar Companies to Race Oncology
Explore companies in related markets and compare their industry and employee estimates.
| Company | Industry / match | Employee estimate | Page |
|---|---|---|---|
| Saxton Group | Events Services | 124 | View company |
| Clarity Pharmaceuticals | Biotechnology Research | 65 | View company |
| Imugene Limited | Biotechnology Research | 36 | View company |
| Paradigm Biopharmaceuticals | Pharmaceutical Manufacturing | 25 | View company |
| BioNSW | Industry Associations | 21 | View company |
| Auric | Technology, Information And Internet | 11 | View company |
| Chimeric Therapeutics | Biotechnology Research | 10 | View company |
| Adnovate Clinical | Biotechnology | 8 | View company |
| HaemaLogiX Ltd | Biotechnology | 7 | View company |
| Island Pharmaceuticals | Biotechnology Research | 3 | View company |